Literature DB >> 19642005

Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.

Jennifer M Yeh1, Sue J Goldie, Karen M Kuntz, Majid Ezzati.   

Abstract

OBJECTIVE: Although gastric cancer incidence is declining in China, trends may differ from historical patterns in developed countries. Our aim was to (1) retrospectively estimate the effects of Helicobacter pylori (H. pylori) and smoking on past gastric cancer incidence and (2) project how interventions on these two risk factors can reduce future incidence.
METHODS: We used a population-based model of intestinal-type gastric cancer to estimate gastric cancer incidence between 1985 and 2050. Disease and risk factor data in the model were from community-based epidemiological studies and national prevalence surveys.
RESULTS: Between 1985 and 2005, age-standardized gastric cancer incidence among Chinese men declined from 30.8 to 27.2 per 100,000 (12%); trends in H. pylori and smoking prevalences accounted for >30% of overall decline. If past risk factor trends continue, gastric cancer incidence will decline an additional 30% by 2050. Yet, annual cases will increase from 116,000 to 201,000 due to population growth and aging. Assuming that H. pylori prevention/treatment and tobacco control are implemented in 2010, the decline in gastric cancer incidence is projected to increase to 33% with universal H. pylori treatment for 20-year-olds, 42% for a hypothetical childhood H. pylori vaccine, and 34% for aggressive tobacco control.
CONCLUSIONS: The decline in gastric cancer incidence has been slower than in developed countries and will be offset by population growth and aging. Public health interventions should be implemented to reduce the total number of cases. Electronic supplementary material The online version of this article (doi:10.1007/s10552-009-9397-9) contains supplementary material, which is available to authorized users.

Entities:  

Mesh:

Year:  2009        PMID: 19642005      PMCID: PMC2904855          DOI: 10.1007/s10552-009-9397-9

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  38 in total

Review 1.  Trend toward a reduced prevalence of Helicobacter pylori infection, chronic gastritis, and gastric cancer in Japan.

Authors:  K Haruma
Journal:  Gastroenterol Clin North Am       Date:  2000-09       Impact factor: 3.806

2.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Authors:  P Correa; E T Fontham; J C Bravo; L E Bravo; B Ruiz; G Zarama; J L Realpe; G T Malcom; D Li; W D Johnson; R Mera
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

3.  Helicobacter pylori infection in children: relation with current household living conditions.

Authors:  W A McCallion; L J Murray; A G Bailie; A M Dalzell; D P O'Reilly; K B Bamford
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

Review 4.  Gastric carcinoma.

Authors:  C S Fuchs; R J Mayer
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

Review 5.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.

Authors: 
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

6.  Smoking cessation in China: findings from the 1996 national prevalence survey.

Authors:  G Yang; J Ma; A Chen; Y Zhang; J M Samet; C E Taylor; K Becker
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

7.  Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States.

Authors:  J E Everhart; D Kruszon-Moran; G I Perez-Perez; T S Tralka; G McQuillan
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

8.  Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii.

Authors:  Meira Epplein; Abraham M Y Nomura; Jean H Hankin; Martin J Blaser; Guillermo Perez-Perez; Grant N Stemmermann; Lynne R Wilkens; Laurence N Kolonel
Journal:  Cancer Causes Control       Date:  2008-03-28       Impact factor: 2.506

9.  The cohort effect and Helicobacter pylori.

Authors:  N Banatvala; K Mayo; F Megraud; R Jennings; J J Deeks; R A Feldman
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

Review 10.  Epidemiology of Helicobacter pylori infection in the People's Republic of China.

Authors:  D Zhou; H Yang
Journal:  Chin Med J (Engl)       Date:  1995-04       Impact factor: 2.628

View more
  8 in total

1.  Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010.

Authors:  Jing-Jing Jing; Hui-Yuan Liu; Jin-Kuan Hao; Li-Na Wang; Yun-Ping Wang; Li-Hua Sun; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

2.  Comparative epidemiology of gastric cancer between Japan and China.

Authors:  Yingsong Lin; Junko Ueda; Shogo Kikuchi; Yukari Totsuka; Wen-Qiang Wei; You-Lin Qiao; Manami Inoue
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

Review 3.  Population screening and treatment of Helicobacter pylori infection.

Authors:  Anthony O'Connor; Colm A O'Morain; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

4.  Endothelial cell-specific molecule-1: a potential serum marker for gastric cancer.

Authors:  Zhongchuan Lv; Yongsheng Fan; Hongbing Chen; Dawei Zhao
Journal:  Tumour Biol       Date:  2014-07-24

5.  Association of smoking, alcohol and NSAIDs use with expression of cag A and cag T genes of Helicobacter pylori in salivary samples of asymptomatic subjects.

Authors:  Pinaki Ghosh; Subhash Laxmanrao Bodhankar
Journal:  Asian Pac J Trop Biomed       Date:  2012-06

Review 6.  Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.

Authors:  Kevin Sze-Hang Liu; Irene Oi-Ling Wong; Wai K Leung
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment.

Authors:  Nayu Ikeda; Manami Inoue; Hiroyasu Iso; Shunya Ikeda; Toshihiko Satoh; Mitsuhiko Noda; Tetsuya Mizoue; Hironori Imano; Eiko Saito; Kota Katanoda; Tomotaka Sobue; Shoichiro Tsugane; Mohsen Naghavi; Majid Ezzati; Kenji Shibuya
Journal:  PLoS Med       Date:  2012-01-24       Impact factor: 11.069

8.  Changing trends in the prevalence of H. pylori infection in Japan (1908-2003): a systematic review and meta-regression analysis of 170,752 individuals.

Authors:  Chaochen Wang; Takeshi Nishiyama; Shogo Kikuchi; Manami Inoue; Norie Sawada; Shoichiro Tsugane; Yingsong Lin
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.